Comparative efficacy and safety of high-dose dual therapy, bismuth-based quadruple therapy and non-bismuth quadruple therapies for Helicobacter pylori infection: a network meta-analysis.

MLA

Xu, Huimei, et al. “Comparative Efficacy and Safety of High-Dose Dual Therapy, Bismuth-Based Quadruple Therapy and Non-Bismuth Quadruple Therapies for Helicobacter Pylori Infection: A Network Meta-Analysis.” European Journal of Gastroenterology & Hepatology, vol. 33, no. 6, June 2021, pp. 775–86. EBSCOhost, https://doi.org/10.1097/MEG.0000000000001835.

APA

Xu, H., Wang, W., Ma, X., Feng, R., Su, Y., Cheng, L., Yang, Y., & Zhang, D. (2021). Comparative efficacy and safety of high-dose dual therapy, bismuth-based quadruple therapy and non-bismuth quadruple therapies for Helicobacter pylori infection: a network meta-analysis. European Journal of Gastroenterology & Hepatology, 33(6), 775–786. https://doi.org/10.1097/MEG.0000000000001835

Chicago

Xu, Huimei, Wancong Wang, Xueni Ma, Rukun Feng, Yujing Su, Long Cheng, Yifan Yang, and Dekui Zhang. 2021. “Comparative Efficacy and Safety of High-Dose Dual Therapy, Bismuth-Based Quadruple Therapy and Non-Bismuth Quadruple Therapies for Helicobacter Pylori Infection: A Network Meta-Analysis.” European Journal of Gastroenterology & Hepatology 33 (6): 775–86. doi:10.1097/MEG.0000000000001835.